Bax is essential for death receptor-mediated apoptosis in human colon cancer cells

Cancer Biotherapy and Radiopharmaceuticals

Volumn 27, Issue 9, 2012, Pages 577-581

  Zhu, Shunqin ^a   Li, Tai ^a   Tan, Juan ^a   Yan, Xiaomin ^a   Zhang, Dunke ^a   Zheng, Chunqin ^a   Chen, Yibiao ^a   Xiang, Zhonghuai ^a   Cui, Hongjuan ^a  

^a SOUTHWEST UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; Colon cancer; Death receptor; p53

Indexed keywords

DEATH RECEPTOR; LIPOCORTIN 5; PROTEIN BAX; PROTEIN P53; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; CELL STRAIN HCT116; COLON CANCER; DNA DAMAGE; DOWN REGULATION; HUMAN; HUMAN CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; VIRAL GENE DELIVERY SYSTEM;

APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CELL CULTURE TECHNIQUES; CELL LINE, TUMOR; COLONIC NEOPLASMS; GENE KNOCKOUT TECHNIQUES; HCT116 CELLS; HUMANS; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84868270102     PISSN: 10849785     EISSN: 15578852     Source Type: Journal    
DOI: 10.1089/cbr.2012.1256     Document Type: Article

References (34)

1. Liu X, Kim CN, Yang J, et al. Induction of apoptotic program in cell-free extracts: Requirement for dATP and cytochrome c. Cell 1996;86:147.
2. Du C, Fang M, Li Y, et al. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminating IAP inhibition. Cell 2000;102:33.
3. Verhagen AM, Ekert PG, Pakusch M, et al. Identification of DIABLO, a mammalian protein that promotes apoptosis by binding to and antagonizing IAP proteins. Cell 2000; 102:43.
4. Skommer J, Brittain T, Raychaudhuri S. Bcl-2 inhibits apoptosis by increasing the time-to-death and intrinsic cellto-cell variations in the mitochondrial pathway of cell death. Apoptosis 2010;15:1223.
5. George J, Banik NL, Ray SK. Genistein induces receptor and mitochondrial pathways and increases apoptosis during BCL-2 knockdown in human malignant neuroblastoma SK-N-DZ cells. J Neurosci Res 2010;88:877.
6. Martinou JC, Youle RJ. Mitochondria in apoptosis: Bcl-2 family members and mitochondrial dynamics. Dev Cell 2011;21:92.
7. Scaffidi C, Fulda S, Srinivasan A, et al. Two CD95 (APO-1/ Fas) signaling pathways. EMBO J 1998;17:1675.
8. Li H, Zhu H, Xu CJ, et al. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 1998;94:491.
9. Luo X, Budihardjo I, Zou H, et al. Bid, a Bcl2 interacting protein, mediates cytochrome c release from mitochondria in response to activation of cell surface death receptors. Cell 1998;94:481.
10. Burns TF, El-Deiry WS. Identification of inhibitors of TRAILinduced death (ITIDs) in the TRAIL-sensitive colon carcinoma cell line SW480 using a genetic approach. J Biol Chem 2001;276:37879.
11. LeBlanc H, Lawrence D, Varfolomeev E, et al. Tumor-cell resistance to death receptor - induced apoptosis through mutational inactivation of the proapoptotic Bcl-2 homolog Bax. Nat Med 2002;8:274.
12. He Q, Huang Y, Sheikh MS. Proteasome inhibitor MG132 upregulates death receptor 5 and cooperates with Apo2L/ TRAIL to induce apoptosis in Bax-proficient and -deficient cells. Oncogene 2004;23:2554.
13. Li W, Jin L, An L. Construction of targeting vector and expression of green fluorescent protein in the silkworm, Antheraea pernyi. DNA Cell Biol 2003;22:441.
14. Ory DS, Neugeboren BA, Mulligan RC. A stable humanderived packaging cell line for production of high titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A 1996;93:11400.
15. Khoo KH, Andreeva A, Fersht AR. Adaptive evolution of p53 thermodynamic stability. J Mol Biol 2009;393:161.
16. Brown JP, Pagano M. Mechanism of p53 degradation. Biochim Biophys Acta 1997;1332:01.
17. Cui H, Schroering A, Ding HF. p53 mediates DNA damaging drug-induced apoptosis through a caspase-9-dependent pathway in SH-SY5Y neuroblastoma cells. Mol Cancer Ther 2002;1:679.
18. el-Deiry WS, Tokino T, Velculescu VE, et al. WAF1, a potential mediator of p53 tumor suppression. Cell 1993;75:817.
19. Barak Y, Juven T, Haffner R, et al. mdm2 expression is induced by wild type p53 activity. EMBO J 1993;12:461.
20. Lim do Y, Park JH. Induction of p53 contributes to apoptosis of HCT-116 human colon cancer cells induced by the dietary compound fisetin. Am J Physiol Gastrointest Liver Physiol 2009;296:G1060.
21. Li W, Du B, Wang T, et al. Kaempferol induces apoptosis in human HCT116 colon cancer cells via the Ataxia-Telangiectasia Mutated-p53 pathway with the involvement of p53 Upregulated Modulator of Apoptosis. Chem Biol Interact 2009;177:121.
22. Sharma N, Ramachandran S, Bowers M, et al. Multiple factors other than p53 influence colon cancer sensitivity to paclitaxel. Cancer Chemother Pharmacol 2000;46:329.
23. Zhang L, Yu J, Park BH, et al. Role of BAX in the apoptotic response to anticancer agents. Science 2000;290:989.
24. Knudson CM, Korsmeyer SJ. Bcl-2 and Bax function independently to regulate cell death. Nat Genet 1997;16:358.
25. Gillissen B, Wendt J, Richter A, et al. Endogenous Bak inhibitors Mcl-1 and Bcl-xL: Differential impact on TRAIL resistance in Bax-deficient carcinoma. J Cell Biol 2010;188:851.
26. Liang X, Liu Y, Zhang Q, et al. Hepatitis B virus sensitizes hepatocytes to TRAIL-induced apoptosis through Bax. J Immunol 2007;178:503.
27. Deng Y, Wu X. Peg3/Pw1 promotes p53-mediated apoptosis by inducing Bax translocation from cytosol to mitochondria. Proc Natl Acad Sci U S A 2000;97:12050.
28. Croker BA, O'Donnell JA, Nowell CJ, et al. Fas-mediated neutrophil apoptosis is accelerated by Bid, Bak, and Bax and inhibited by Bcl-2 and Mcl-1. Proc Natl Acad Sci USA 2011;108:13135.
29. Wiley SR, Schooley K, Smolak PJ, et al. Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995;3:673.
30. Walczak H, Miller RE, Ariail K, et al. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo. Nat Med 1999;5:157.
31. Ashkenazi A, Pai RC, Fong S, et al. Safety and antitumor activity of recombinant soluble Apo2 ligand. J Clin Invest 1999;104:155.
32. Pan G, Ni J, Wei YF, et al. An antagonist decoy receptor and a death domain-containing receptor for TRAIL. Science 1997;277:815.
33. Sheridan JP, Marsters SA, Pitti RM, et al. Control of TRAILinduced apoptosis by a family of signaling and decoy receptors. Science 1997;277:818.
34. Degli-Esposti MA, Smolak PJ, Walczak H, et al. Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family. J Exp Med 1997;186: 1165.